Published ahead of print on January 3, 2008, doi:10.1164/rccm.200710-1606OC Am. J. Respir. Crit. Care Med., Volume 177, Number 6, March 2008, 646-653 A more recent version of this article appeared on March 15, 2008
Submitted on October 31, 2007 Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell DiseaseArmand Mekontso Dessap1*,1 Groupe Hospitalier Henri Mondor-Albert Chenevier, Medical Intensive Care Unit, Creteil, France; Universite Paris XII, INSERM Unite 841, IMRB, Equipe 8, Faculte de Medecine, IFR10, Creteil, France, 2 Groupe Hospitalier Henri Mondor-Albert Chenevier, Medical Intensive Care Unit, Creteil, France, 3 Groupe Hospitalier Henri Mondor-Albert Chenevier, Sickle Cell Disease Center, Creteil, France, 4 Groupe Hospitalier Henri Mondor-Albert Chenevier, Public Health Unit, Creteil, France, 5 Universite Paris XII, INSERM Unite 841, IMRB, Equipe 8, Faculte de Medecine, IFR10, Creteil, France, 6 Groupe Hospitalier Henri Mondor-Albert Chenevier, Internal Medicine Unit, Creteil, France, 7 Groupe Hospitalier Henri Mondor-Albert Chenevier, Pulmonary Disease Unit, Creteil, France; Universite Paris XII, INSERM Unite 841, IMRB, Equipe 8, Faculte de Medecine, IFR10, Creteil, France * To whom correspondence should be addressed. E-mail: armand.dessap{at}hmn.aphp.fr.
Rationale: Steady-state mild pulmonary hypertension is a risk factor for death in adults with sickle cell disease. Acute pulmonary hypertension has been reported during exercise and vasoocclusive pain crisis in these patients.
Objectives: The aim of the present study was to evaluate changes in pulmonary pressures and cardiac biomarkers during severe acute chest syndrome and their associations with mortality.
Methods: We prospectively evaluated 70 consecutive adults who received standardized treatment in our intensive care unit for a total of 84 episodes. At admission, cardiac biomarkers were measured. Transthoracic echocardiography was performed for pulmonary hypertension assessment via measurement of tricuspid regurgitant jet velocity and was repeated when possible after resolution.
Measurements and Results: Tricuspid jet velocity was <2.5 m/s in 34 (40%) of the 84 episodes, 2.5 to 2.9 m/s in 19 (23%), and Key words: hemoglobinopathies, lung injury, pulmonary pressure, cardiac biomarkers, echocardiography
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||